MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

Abu Dhabi: In good news for parents, Abu Dhabi is developing a new assessment system to evaluate the quality of offerings and ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

A take-at-home tablet for multiple sclerosis (MS) is set to be more broadly rolled out on the NHS, potentially benefiting thousands of patients in England. The move will also “significantly free up ...

The escalating global plastics crisis, exemplified by the >31 million tons of PET production in 2019, necessitates efficient recycling strategies as ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

The Justice Dept. is investigating if egg producers are working together to raise prices or reduce supply. "Dude is telling ...

Methanolysis of polyethylene terephthalate to dimethyl terephthalate is a sustainable route for recycling of polyethylene ...

Kevin Schwietz, 34, and Kelsey Schwietz, 32, were each charged with controlled substance crimes in Sherburne County court.